Upstream clopidogrel use and the efficacy and safety of early eptifbatide treatment in patients with acute coronary syndrome: An analysis from the early glycoprotein IIb/IIIa inhibition in patients with non-ST-segment elevation acute coronary syndrome (EARLY ACS) trial.